CALCULATE YOUR SIP RETURNS

Max India to Invest ₹219 Crore in Subsidiaries

Written by: Team Angel OneUpdated on: Feb 7, 2025, 2:48 PM IST
Max India has approved an investment of ₹219 crore in its subsidiaries, Antara Senior Living and Antara Assisted Care, for business expansion in FY 2025-26.
Max India to Invest ₹219 Crore in Subsidiaries
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Max India has approved an investment of up to ₹219 crore in its wholly owned subsidiaries, Antara Senior Living Limited and Antara Assisted Care Services Limited, for the financial year 2025-26. The funds will be infused through a rights issue or inter-corporate deposits (ICDs) in multiple phases, depending on the subsidiaries’ requirements.

As of February 7, 2025, at 12:03 PM, Max India Ltd. is trading at ₹240.60, down ₹12.10 (-4.79%) for the day, declining 23.81% over the past six months but gaining 13.52% in the past year.

Allocation of Funds

The investment will be divided as follows:

  • ₹71 crore for Antara Senior Living Limited
  • ₹148 crore for Antara Assisted Care Services Limited

The company will either subscribe to new equity or preference shares under rights issues or provide ICDs to support the funding needs of these businesses.

Purpose of the Investment

The funding is aimed at meeting the business expansion and operational requirements of both subsidiaries. Antara Senior Living Limited focuses on senior living communities, while Antara Assisted Care Services Limited provides assisted care services.

India’s senior population (aged 60 and above) is to reach 347 million by 2050, increasing the demand for senior living and healthcare services. Companies operating in this space are expanding to meet the growing requirements of this segment.

Regulatory Filings

The details of this investment have been disclosed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The required information is included in ‘Annexure-C’ of the company’s filing.

Investment Timeline

The capital infusion will take place over multiple phases throughout the financial year 2025-26. The company will assess the funding needs and proceed with the investment accordingly. This approval allows Max India to allocate capital towards its subsidiaries as they expand their operations and services.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Published on: Feb 7, 2025, 2:48 PM IST

Team Angel One

Team Angel One is a group of experienced financial writers that deliver insightful articles on the stock market, IPO, economy, personal finance, commodities and related categories.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 2.5 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 2.5 Cr+ happy customers